1. Home
  2. GATX vs ICLR Comparison

GATX vs ICLR Comparison

Compare GATX & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GATX Corporation

GATX

GATX Corporation

HOLD

Current Price

$198.34

Market Cap

7.0B

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$102.53

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GATX
ICLR
Founded
1898
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
8.2B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
GATX
ICLR
Price
$198.34
$102.53
Analyst Decision
Strong Buy
Buy
Analyst Count
2
13
Target Price
$215.50
$178.62
AVG Volume (30 Days)
174.7K
992.7K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
1.33%
N/A
EPS Growth
17.22
N/A
EPS
9.12
N/A
Revenue
$1,740,400,000.00
N/A
Revenue This Year
$42.21
N/A
Revenue Next Year
$3.35
N/A
P/E Ratio
$21.71
$12.91
Revenue Growth
9.77
N/A
52 Week Low
$141.28
$66.57
52 Week High
$205.56
$211.00

Technical Indicators

Market Signals
Indicator
GATX
ICLR
Relative Strength Index (RSI) 69.19 39.35
Support Level $166.88 $95.75
Resistance Level $199.00 $114.75
Average True Range (ATR) 3.80 4.87
MACD 0.69 -0.82
Stochastic Oscillator 70.27 13.20

Price Performance

Historical Comparison
GATX
ICLR

About GATX GATX Corporation

GATX Corp leases transportation assets, including railcars, aircraft spare engines, and tank containers, to customers in North America, Europe, and India. The company's reportable business segments are: Rail North America, Rail International, Engine Leasing, and Other. The majority of its revenue is generated from the Rail North America segment, which is composed of the company's operations in the United States, Canada, and Mexico. This segment mainly provides railcars pursuant to full-service leases under which it maintains the railcars, pays ad valorem taxes and insurance, and provides other ancillary services.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: